CYAD Share Price Performance
€0.26
-0.13 (-33.33%)
Price €0.26
Share Pricen/a
Celyad Oncology SA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CYAD Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Celyad Oncology SA Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 23, 2026
- 0.019
- 61.90%
- 3,952.38%
- 0%
About CYAD
- Founded
- 2004
- Employees
- 5
- CEO
- WebsiteView website
Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.